Impact of Second-Tier Testing on the Effectiveness of Newborn Screening

被引：19

作者：

Chace, Donald H. ^{[1
]}

Hannon, W. Harry ^{[2
]}

机构：

[1] Pediatrix Ctr Res Educ & Qual, Pediatrix Med Grp, Sunrise, FL 33323 USA

[2] Ctr Dis Control & Prevent, Div Sci Lab, Atlanta, GA USA

来源：

CLINICAL CHEMISTRY | 2010年 / 56卷 / 11期

关键词：

TANDEM MASS-SPECTROMETRY;

D O I：

10.1373/clinchem.2010.153494

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：1653 / 1655

页数：3

共 50 条

[1] Second-tier strategies in newborn screening - potential and limitations
Gramer, Gwendolyn
Hoffmann, Georg F.
[J]. MEDIZINISCHE GENETIK, 2022, 34 (01) : 21 - 28
[2] Advantages of the implementation of a second-tier test strategy in the newborn screening
Berto, M. Santes
Bauca, J. M.
Alaejos, A. Rubio
Rodriguez, M. Pons
Gual, M. Amengual
Adrover, A. Saiz
Martinez, C. Carrasco
Ferrer, L. Canals
Garcia, B. Garcia
Bauza, J. Robles
[J]. CLINICA CHIMICA ACTA, 2024, 558
[3] Rapid second-tier testing for newborn screening and therapeutic monitoring of maple syrup urine disease
Sinclair, Graham
van Karnebeek, Clara
Salvarinova, Ramona
Ho, Gloria
Ueda, Keiko
Cheng, Barbara
Giezen, Alette
Stockler, Sylvia
Vallance, Hilary
[J]. CLINICAL BIOCHEMISTRY, 2014, 47 (15) : 149 - +
[4] Second-Tier Testing for 21-Hydroxylase Deficiency in the Netherlands: A Newborn Screening Pilot Study
Stroek, Kevin
Ruiter, An
Van der Linde, Annelieke
Ackermans, Mariette
Bouva, Marelle J.
Engel, Henk
Jakobs, Bernadette
Kemper, Evelien A.
Van den Akker, Erica L. T.
Van Albada, Mirjam E.
Bocca, Gianni
Finken, Martijn J. J.
Hannema, Sabine E.
Houdijk, E. C. A. Mieke
Van der Kamp, Hetty J.
Van Tellingen, Vera
Van Trotsenburg, A. S. Paul
Zwaveling-Soonawala, Nitash
Bosch, Annet M.
de Jonge, Robert
Heijboer, Annemieke C.
Claahsen-Van der Grinten, Hedi L.
Boelen, Anita
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (11): : E4487 - E4496
[5] Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I
Peck, Dawn S.
Lacey, Jean M.
White, Amy L.
Pino, Gisele
Studinski, April L.
Fisher, Rachel
Ahmad, Ayesha
Spencer, Linda
Viall, Sarah
Shallow, Natalie
Siemon, Amy
Hamm, J. Austin
Murray, Brianna K.
Jones, Kelly L.
Gavrilov, Dimitar
Oglesbee, Devin
Raymond, Kimiyo
Matern, Dietrich
Rinaldo, Piero
Tortorelli, Silvia
[J]. INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2020, 6 (01)
[6] Impact of the inclusion of second-tier tests in the newborn screening program of Catalonia and in other international programs
Pajares Garcia, Sonia
Lopez Galera, Rosa Ma
Marin Soria, Jose Luis
Argudo Ramirez, Ana
de Aledo-Castillo, Jose Manuel Gonzalez
Ribes Rubio, Antonia
Prats Viedma, Blanca
Asso Ministral, Laia
Garcia-Villoria, Judit
[J]. REVISTA ESPANOLA DE SALUD PUBLICA, 2020, 94
[7] Validation of a targeted metabolomics panel for improved second-tier newborn screening
Mak, Justin
Peng, Gang
Le, Anthony
Gandotra, Neeru
Enns, Gregory M.
Scharfe, Curt
Cowan, Tina M.
[J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2023, 46 (02) : 194 - 205
[8] Clinical Utility of Second-tier Testing in Newborn Screening for Congenital Adrenal Hyperplasia: The Hong Kong Experience
Yeung, M. C. W.
Chan, T. C. H.
Mak, C. M.
[J]. HONG KONG JOURNAL OF PAEDIATRICS, 2020, 25 (01) : 3 - 7
[9] Next-generation sequencing as a second-tier diagnostic test for newborn screening
Luo, Xiaomei
Wang, Ruifang
Fan, Yanjie
Gu, Xuefan
Yu, Yongguo
[J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2018, 31 (08): : 927 - 931
[10] Combining newborn metabolic and DNA analysis for second-tier testing of methylmalonic acidemia
Peng, Gang
Shen, Peidong
Gandotra, Neeru
Le, Anthony
Fung, Eula
Jelliffe-Pawlowski, Laura
Davis, Ronald W.
Enns, Gregory M.
Zhao, Hongyu
Cowan, Tina M.
Scharfe, Curt
[J]. GENETICS IN MEDICINE, 2019, 21 (04) : 896 - 903

← 1 2 3 4 5 →